183 related articles for article (PubMed ID: 20943873)
1. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.
Riffelmann M; Thiel K; Schmetz J; Wirsing von Koenig CH
J Clin Microbiol; 2010 Dec; 48(12):4459-63. PubMed ID: 20943873
[TBL] [Abstract][Full Text] [Related]
2. Comparison of commercially available immunoblot assays measuring IgG and IgA antibodies to Bordetella pertussis antigens.
Kennerknecht N; Riffelmann M; Schmetz J; Wirsing von König CH
Eur J Clin Microbiol Infect Dis; 2011 Dec; 30(12):1531-5. PubMed ID: 21503838
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of commercial serological assays measuring Bordetella pertussis IgG antibodies.
Fedele G; Leone P; Bellino S; Schiavoni I; Pavia C; Lazzarotto T; Stefanelli P
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):157-162. PubMed ID: 29221733
[TBL] [Abstract][Full Text] [Related]
4. Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.
Kösters K; Riffelmann M; Dohrn B; von König CH
Clin Diagn Lab Immunol; 2000 May; 7(3):422-6. PubMed ID: 10799456
[TBL] [Abstract][Full Text] [Related]
5. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I
Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
[TBL] [Abstract][Full Text] [Related]
6. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.
Xing D; Wirsing von König CH; Newland P; Riffelmann M; Meade BD; Corbel M; Gaines-Das R
Clin Vaccine Immunol; 2009 Mar; 16(3):303-11. PubMed ID: 19109448
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US.
Pawloski LC; Plikaytis BD; Martin MD; Martin SW; Prince HE; Lapé-Nixon M; Tondella ML
J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e15-e21. PubMed ID: 27451419
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Western immunobloting to an enzyme-linked immunosorbent assay for the determination of anti-Bordetella pertussis antibodies.
Merrigan SD; Welch RJ; Litwin CM
Clin Vaccine Immunol; 2011 Apr; 18(4):615-20. PubMed ID: 21307277
[TBL] [Abstract][Full Text] [Related]
9. Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.
Cherry JD; Heininger U; Richards DM; Storsaeter J; Gustafsson L; Ljungman M; Hallander HO
Clin Vaccine Immunol; 2010 May; 17(5):741-7. PubMed ID: 20335431
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
Prince HE; Lapé-Nixon M; Matud J
Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of IgG, IgA, and IgM to Bordetella pertussis antigens in patients with pertussis].
Zaĭtsev EM; Mazurova IL; Petrova MS; Krasnoproshina LI; Zakharova NS
Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):23-6. PubMed ID: 19186540
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of an Australian pertussis toxin IgG and IgA enzyme immunoassay.
May ML; Doi SA; King D; Evans J; Robson JM
Clin Vaccine Immunol; 2012 Feb; 19(2):190-7. PubMed ID: 22131356
[TBL] [Abstract][Full Text] [Related]
13. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.
Kapasi A; Meade BD; Plikaytis B; Pawloski L; Martin MD; Yoder S; Rock MT; Coddens S; Haezebroeck V; Fievet-Groyne F; Bixler G; Jones C; Hildreth S; Edwards KM; Messonnier NE; Tondella ML
Clin Vaccine Immunol; 2012 Jan; 19(1):64-72. PubMed ID: 22116688
[TBL] [Abstract][Full Text] [Related]
15. Antibody Specificity Following a Recent
Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
Front Immunol; 2019; 10():1364. PubMed ID: 31275314
[No Abstract] [Full Text] [Related]
16. Development and validation of an Australian in-house anti-pertussis toxin IgG and IgA enzyme immunoassay.
May ML; Evans J; Riley J; Lambkin G; Robson JM
Pathology; 2013 Feb; 45(2):172-80. PubMed ID: 23250035
[TBL] [Abstract][Full Text] [Related]
17. EUVAC.NET collaborative study: evaluation and standardisation of serology for diagnosis of pertussis.
Xing D; Markey K; Newland P; Rigsby P; Hockley J; He Q
J Immunol Methods; 2011 Sep; 372(1-2):137-45. PubMed ID: 21782823
[TBL] [Abstract][Full Text] [Related]
18. Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.
Aase A; Herstad TK; Merino S; Brandsdal KT; Berdal BP; Aleksandersen EM; Aaberge IS
Clin Vaccine Immunol; 2007 Jul; 14(7):855-62. PubMed ID: 17507542
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum anti-pertussis toxin IgA antibodies for the diagnosis of Bordetella pertussis infection in young children.
Chen Z; Liu X; Zhang Y; Peng X; Zhang N; Chen N; Li Y; He Q
J Infect Public Health; 2023 Aug; 16(8):1167-1173. PubMed ID: 37269695
[TBL] [Abstract][Full Text] [Related]
20. Improvement in serological diagnosis of pertussis by external quality assessment.
Markey K; Douglas-Bardsley A; Asokanathan C; Fry NK; Barkoff AM; Bacci S; Ködmön C; He Q
J Med Microbiol; 2019 May; 68(5):741-747. PubMed ID: 30990403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
